Parkinson's disease
| 4 min read
Researchers have identified a distinctive gut microbiome pattern linked to Parkinson’s disease that appears in both diagnosed patients and a subset of symptom-free individuals who may already be on a disease trajectory.
| 6 min read
Emerging data shows alpha synuclein may be present in the majority of neurodegenerative disease cases, reshaping how clinicians understand dementia and Parkinson’s.
| 4 min read
FDA approvals, mass spectrometry advancements, personalized gene therapies, and more led the news this week.
| 4 min read
Researchers uncover how microbes targeting the colon’s mucus may explain treatment-resistant constipation in Parkinson’s disease and other patients.
| 3 min read
A Phase 1 trial at Keck Medicine of USC is testing whether implanted iPSC-derived neurons can restore dopamine signaling and improve motor function.
| 3 min read
By combining human-derived data with AI-driven discovery, the partnership seeks to tackle Parkinson’s disease heterogeneity and improve target selection.
| 6 min read
New software and hardware tools that collect data while a person types can detect fine motor impairment — a possible sign of neurodegeneration.
| 4 min read
An FDA rejection, Takeda restructuring, Trump initiatives and more lead the news this week.
Available on Demand
From vascularized organoids to Parkinson's disease in a dish, scientists are pushing the boundaries of 3D cell research.
| 4 min read
Vertex-Enlaza autoimmune drugs, DNA-wrapped CRISPR, HHS staff demand Kennedy’s resignation, and more lead the news this week.
